Down for the count in acute myeloid leukemia Journal Article


Authors: Goldberg, A. D.; Tallman, M. S.
Article Title: Down for the count in acute myeloid leukemia
Abstract: In this issue of Blood, Rauch et al provide evidence for a novel mechanism to explain a fundamental yet enigmatic observation that has plagued hematologists for decades: the decline in nonleukemic hematopoiesis in the bone marrow of patients with acute myeloid leukemia (AML). The authors found that high expression of the thrombopoietin (TPO) receptor MPL on AML blasts predicts neutropenia and thrombocytopenia, and that AML blasts expressing high levels of MPL deplete TPO in cell culture and in mouse models. Rather than crowding out normal bone marrow hematopoietic stem cells (HSCs), might MPL-expressing AML blasts impair hematopoiesis by stealing the cytokine TPO?1 © 2016 by The American Society of Hematology.
Journal Title: Blood
Volume: 128
Issue: 18
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-11-03
Start Page: 2195
End Page: 2197
Language: English
DOI: 10.1182/blood-2016-09-738765
PROVIDER: scopus
PUBMED: 27811189
DOI/URL:
Notes: Note -- Export Date: 6 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman
  2. Aaron David Goldberg
    106 Goldberg